For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AMLHOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., ...

Clonal hematopoiesis in chronic lymphocytic leukemia is widespread, shaping cytopenias, cardiovascular risk, and chemotoxicity. As patients age on therapy for their chronic lymphocytic leukemia (CLL), ...

Everyone’s favorite bracket challenge has returned. That’s right—it’s time once again for Fierce Pharma Marketing’s annual ...

Follow Layla’s inspiring journey as music becomes her source of strength and comfort while battling leukemia. See how melody, rhythm, and creativity bring hope, courage, and joy to her fight.

When Jeff Urso received word he was facing a serious health crisis, he sprang into action — not just for himself, but for children confronting similar battles.

Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That superhero is a gene called TP53, and for decades scientists have known it as ...

The 2026 Cancer in Iowa Report, published by the Iowa Cancer Registry, is highlighting insights into cancer trends among Iowa ...

Drs. Jessa Miller and Amrita Ray discuss the paradox of increasing incidence and decreasing mortality in AIFRS.

This year’s Rare Disease Day event Feb. 27 at the Jacobs School of Medicine and Biomedical Sciences focused on updates in research and diagnostics, and advancements in treatment.